|
DE75755C
(de)
|
|
1894-06-14 |
DAHL & COMP, in Barmen |
Verfahren zur Darstellung von aromatisch substituirten Amidodinaphtylmethanen.
|
|
WO1994027627A1
(en)
|
1993-05-24 |
1994-12-08 |
Smithkline Beecham Corporation |
Hemoregulatory peptides
|
|
US6037157A
(en)
*
|
1995-06-29 |
2000-03-14 |
Abbott Laboratories |
Method for improving pharmacokinetics
|
|
US5935982A
(en)
*
|
1997-02-28 |
1999-08-10 |
The University Of North Carolina At Chapel Hill |
Methods of treating retroviral infection and compounds useful therefor
|
|
US6235493B1
(en)
*
|
1997-08-06 |
2001-05-22 |
The Regents Of The University Of California |
Amino acid substituted-cresyl violet, synthetic fluorogenic substrates for the analysis of agents in individual in vivo cells or tissue
|
|
CZ289425B6
(cs)
|
1998-05-20 |
2002-01-16 |
Eli Lilly And Company |
Imidazo[1,2-a] pyridinové sloučeniny, jejich pouľití a farmaceutický přípravek s jejich obsahem
|
|
US6911462B2
(en)
*
|
1998-05-22 |
2005-06-28 |
Avanir Pharmaceuticals |
Benzimidazole compounds for regulating IgE
|
|
RU2236220C2
(ru)
|
1998-05-22 |
2004-09-20 |
Аванир Фармасьютикэлз |
Аналоги бензимидазола в качестве понижающих регуляторов ige
|
|
US6369091B1
(en)
*
|
1998-05-22 |
2002-04-09 |
Avanir Pharmaceuticals |
Benzimidazole analogs as down-regulators of IgE
|
|
US6919366B2
(en)
*
|
1998-05-22 |
2005-07-19 |
Avanir Pharmaceuticals |
Benzimidazole derivatives as modulators of IgE
|
|
US6387885B1
(en)
|
1998-08-26 |
2002-05-14 |
Abbott Laboratories |
3′,3′-N-bis-desmethyl-3′-N-cycloalkyl erythromycin derivatives as LHRH antagonists
|
|
WO2001046196A1
(en)
*
|
1999-12-21 |
2001-06-28 |
Sugen, Inc. |
4-substituted 7-aza-indolin-2-ones and their use as protein kinase inhibitors
|
|
HK1052509B
(en)
|
2000-08-14 |
2007-09-07 |
Ortho-Mcneil Pharmaceutical, Inc. |
Substituted pyrazole
|
|
EP1341788B1
(en)
|
2000-12-15 |
2005-08-10 |
Glaxo Group Limited |
Pyrazolopyridines
|
|
JP4169246B2
(ja)
|
2001-03-16 |
2008-10-22 |
富士フイルム株式会社 |
ヘテロ環化合物及びそれを用いた発光素子
|
|
CN101624391A
(zh)
*
|
2001-06-11 |
2010-01-13 |
病毒化学医药公司 |
用作黄病毒感染抗病毒剂的噻吩衍生物
|
|
EP2335700A1
(en)
*
|
2001-07-25 |
2011-06-22 |
Boehringer Ingelheim (Canada) Ltd. |
Hepatitis C virus polymerase inhibitors with a heterobicylic structure
|
|
RU2286343C2
(ru)
|
2001-08-10 |
2006-10-27 |
Орто-Макнейл Фармасьютикал, Инк. |
Замещенные пиразолы
|
|
MY151199A
(en)
*
|
2001-11-02 |
2014-04-30 |
Rigel Pharmaceuticals Inc |
Substituted diphenyl heterocycles useful for treating hcv infection
|
|
JP3925265B2
(ja)
|
2002-03-25 |
2007-06-06 |
コニカミノルタホールディングス株式会社 |
有機エレクトロルミネッセンス素子及びそれを用いた表示装置
|
|
TW200304820A
(en)
|
2002-03-25 |
2003-10-16 |
Avanir Pharmaceuticals |
Use of benzimidazole analogs in the treatment of cell proliferation
|
|
MXPA04012642A
(es)
*
|
2002-06-14 |
2005-03-23 |
Merck & Co Inc |
Inhibidores de la cinesina mitotica.
|
|
CA2491895C
(en)
|
2002-07-09 |
2011-01-18 |
Vertex Pharmaceuticals Incorporated |
Inhibitors of c-jun n-terminal kinases (jnk) and other protein kinases
|
|
WO2004014852A2
(en)
|
2002-08-12 |
2004-02-19 |
Bristol-Myers Squibb Company |
Iminothiazolidinones as inhibitors of hcv replication
|
|
GB0229518D0
(en)
*
|
2002-12-19 |
2003-01-22 |
Astrazeneca Ab |
Chemical compounds
|
|
TW200508224A
(en)
*
|
2003-02-12 |
2005-03-01 |
Bristol Myers Squibb Co |
Cyclic derivatives as modulators of chemokine receptor activity
|
|
US7132426B2
(en)
|
2003-07-14 |
2006-11-07 |
Arena Pharmaceuticals, Inc. |
Fused-aryl and heteroaryl derivatives as modulators of metabolism and the prophylaxis and treatment of disorders related thereto
|
|
CA2534649A1
(en)
|
2003-08-01 |
2005-02-10 |
Genelabs Technologies, Inc. |
Bicyclic imidazol derivatives against flaviviridae
|
|
WO2005026129A1
(en)
|
2003-09-15 |
2005-03-24 |
Gpc Biotech Ag |
Pharmaceutically active 4,6-disubstituted aminopyrimidine derivatives as modulators of protein kinases
|
|
CA2543696A1
(en)
*
|
2003-10-27 |
2005-05-12 |
Vertex Pharmaceuticals Incorporated |
Combinations for hcv treatment
|
|
CA2545422C
(en)
|
2003-12-03 |
2015-06-02 |
Cytopia Research Pty Ltd |
Tubulin inhibitors
|
|
BRPI0401908A
(pt)
|
2004-06-04 |
2006-01-17 |
Univ Rio De Janeiro |
Compostos inibidores de serina protease, processo de obtenção e uso para tratamento de flaviviroses
|
|
EP1765332A2
(en)
*
|
2004-06-17 |
2007-03-28 |
Cengent Therapeutics, Inc. |
Trisubstituted nitrogen modulators of tyrosine phosphatases
|
|
US7772271B2
(en)
*
|
2004-07-14 |
2010-08-10 |
Ptc Therapeutics, Inc. |
Methods for treating hepatitis C
|
|
BRPI0513811A
(pt)
|
2004-07-27 |
2008-07-15 |
Gilead Sciences Inc |
imidazo [4,5-d] pirimidinas, seus usos e processos de preparação
|
|
MX2007001661A
(es)
|
2004-08-13 |
2007-04-23 |
Praecis Pharm Inc |
Metodos y composiciones para modular la actividad del receptor de esfingosina -1 fosfato (sip).
|
|
GB0501964D0
(en)
|
2005-01-31 |
2005-03-09 |
Arrow Therapeutics Ltd |
Chemical compounds
|
|
CN101146793A
(zh)
*
|
2005-02-16 |
2008-03-19 |
先灵公司 |
具有cxcr3拮抗剂活性的新的杂环取代了的吡啶或苯基化合物
|
|
WO2006093867A1
(en)
*
|
2005-02-28 |
2006-09-08 |
The Rockefeller University |
Structure of the hepatitits c virus ns5a protein
|
|
US20060235036A1
(en)
|
2005-04-15 |
2006-10-19 |
Doherty Elizabeth M |
Vanilloid receptor ligands and their use in treatments
|
|
US8143288B2
(en)
|
2005-06-06 |
2012-03-27 |
Bristol-Myers Squibb Company |
Inhibitors of HCV replication
|
|
PE20070099A1
(es)
*
|
2005-06-30 |
2007-02-06 |
Janssen Pharmaceutica Nv |
N-heteroarilpiperazinil ureas como moduladores de la amida hidrolasa del acido graso
|
|
JP2009501217A
(ja)
*
|
2005-07-15 |
2009-01-15 |
アストラゼネカ アクチボラグ |
治療薬
|
|
BRPI0619730A2
(pt)
|
2005-12-12 |
2011-10-11 |
Genelabs Tech Inc |
compostos antivirais de n-(anel aromático de 5 membros)-amido
|
|
BRPI0619733A2
(pt)
|
2005-12-12 |
2011-10-11 |
Genelabs Tech Inc |
compostos antivirais de n-(anel aromático de 6 membros)-amido
|
|
CA2634699A1
(en)
*
|
2005-12-21 |
2007-06-28 |
Decode Genetics Ehf |
N-linked aryl heteroaryl inhibitors of lta4h for treating inflammation
|
|
US7915411B2
(en)
*
|
2005-12-21 |
2011-03-29 |
Abbott Laboratories |
Anti-viral compounds
|
|
EP1979348B1
(en)
*
|
2005-12-21 |
2012-01-18 |
Abbott Laboratories |
Anti-viral compounds
|
|
ATE475660T1
(de)
|
2005-12-21 |
2010-08-15 |
Abbott Lab |
Antivirale verbindungen
|
|
WO2007082554A1
(en)
|
2006-01-23 |
2007-07-26 |
Istituto Di Ricerche Di Biologia Molecolare P Angeletti Spa |
Modulators of hcv replication
|
|
AU2007250443B2
(en)
|
2006-05-16 |
2013-06-13 |
Pharmascience Inc. |
IAP BIR domain binding compounds
|
|
MX2008015662A
(es)
*
|
2006-06-08 |
2009-01-12 |
Lilly Co Eli |
Nuevos receptores antagonistas de la hormona concentradora de melanina (mch).
|
|
ES2392104T3
(es)
|
2006-06-16 |
2012-12-04 |
Syngenta Participations Ag |
Derivados de carboxamida etenílica útiles como microbiocidas
|
|
WO2008014238A2
(en)
|
2006-07-24 |
2008-01-31 |
Tetralogic Pharmaceuticals Corporation |
Dimeric iap inhibitors
|
|
US20100056495A1
(en)
|
2006-07-24 |
2010-03-04 |
Tetralogic Pharmaceuticals Corporation |
Dimeric iap inhibitors
|
|
US8303944B2
(en)
*
|
2006-08-11 |
2012-11-06 |
Bristol-Myers Squibb Company |
Hepatitis C virus inhibitors
|
|
US7759495B2
(en)
*
|
2006-08-11 |
2010-07-20 |
Bristol-Myers Squibb Company |
Hepatitis C virus inhibitors
|
|
US7659270B2
(en)
*
|
2006-08-11 |
2010-02-09 |
Bristol-Myers Squibb Company |
Hepatitis C virus inhibitors
|
|
US8329159B2
(en)
|
2006-08-11 |
2012-12-11 |
Bristol-Myers Squibb Company |
Hepatitis C virus inhibitors
|
|
US20100158862A1
(en)
*
|
2006-08-11 |
2010-06-24 |
Bristol-Myers Squibb Company |
Hepatitis C Virus Inhibitors
|
|
US7745636B2
(en)
*
|
2006-08-11 |
2010-06-29 |
Bristol-Myers Squibb Company |
Hepatitis C virus inhibitors
|
|
PE20080906A1
(es)
|
2006-08-17 |
2008-07-05 |
Kemia Inc |
Derivados heteroarilo como inhibidores de citocina
|
|
US20100055071A1
(en)
*
|
2006-11-21 |
2010-03-04 |
Martin Robert Leivers |
Anti-Viral Compounds
|
|
US20080181866A1
(en)
|
2006-11-21 |
2008-07-31 |
Genelabs Technologies, Inc. |
Amido Anti-viral Compounds
|
|
US8236950B2
(en)
|
2006-12-20 |
2012-08-07 |
Abbott Laboratories |
Anti-viral compounds
|
|
WO2008074450A2
(en)
|
2006-12-20 |
2008-06-26 |
Nicox S.A. |
Non-peptidic renin inhibitors nitroderivatives
|
|
JP5454943B2
(ja)
*
|
2007-04-12 |
2014-03-26 |
ジョイアント ファーマスーティカルズ、インク. |
抗癌剤として有用なsmac模倣二量体及び三量体
|
|
US7741347B2
(en)
|
2007-05-17 |
2010-06-22 |
Bristol-Myers Squibb Company |
Hepatitis C virus inhibitors
|
|
PE20090717A1
(es)
|
2007-05-18 |
2009-07-18 |
Smithkline Beecham Corp |
Derivados de quinolina como inhibidores de la pi3 quinasa
|
|
CL2008001631A1
(es)
|
2007-06-06 |
2009-01-02 |
Smithkline Beecham Corp |
Compuestos derivados de heterociclos sustituidos, con la presencia de un grupo fenoxi, inhibidores de transcriptasa inversa; composicion farmaceutica; y uso en el tratamiento de infecciones virales por vih.
|
|
WO2009003009A1
(en)
|
2007-06-26 |
2008-12-31 |
Enanta Pharmaceuticals, Inc. |
Substituted pyrrolidine as anti-infectives
|
|
EP2185154A2
(en)
|
2007-08-03 |
2010-05-19 |
Schering Corporation |
Method of treating cxcr3 mediated diseases using heterocyclic substituted piperazines
|
|
US7728027B2
(en)
*
|
2007-08-08 |
2010-06-01 |
Bristol-Myers Squibb Company |
Process for synthesizing compounds useful for treating hepatitis C
|
|
US8629171B2
(en)
*
|
2007-08-08 |
2014-01-14 |
Bristol-Myers Squibb Company |
Crystalline form of methyl ((1S)-1-((25)-2-(5-(4'-(2-((25)-1((2S)-2-((methoxycarbonyl)amino)-3-methylbutanoyl)-2-pyrrolidinyl)-1H-imidazol-2-yl)-1-pyrrolidinyl)carbonyl)-2-methylpropyl)carbamate dihydrochloride salt
|
|
US20090047247A1
(en)
*
|
2007-08-13 |
2009-02-19 |
Yao-Ling Qiu |
Pyrrolidine Derivatives
|
|
GB0801199D0
(en)
|
2008-01-23 |
2008-02-27 |
Acal Energy Ltd |
Fuel cells
|
|
JP5581219B2
(ja)
|
2008-01-25 |
2014-08-27 |
ミレニアム ファーマシューティカルズ, インコーポレイテッド |
チオフェンおよびホスファチジルイノシトール3−キナーゼ(pi3k)阻害薬としてのその使用
|
|
JP2011511841A
(ja)
|
2008-02-12 |
2011-04-14 |
ブリストル−マイヤーズ スクイブ カンパニー |
C型肝炎ウイルス阻害剤
|
|
ATE551337T1
(de)
|
2008-02-12 |
2012-04-15 |
Bristol Myers Squibb Co |
Inhibitoren des hepatitis-c-virus
|
|
US8147818B2
(en)
|
2008-02-13 |
2012-04-03 |
Bristol-Myers Squibb Company |
Hepatitis C virus inhibitors
|
|
HRP20120706T1
(hr)
|
2008-02-13 |
2012-09-30 |
Bristol-Myers Squibb Company |
Imidazolil bifenil imidazoli kao inhibitori virusa hepatitisa c
|
|
US7704992B2
(en)
|
2008-02-13 |
2010-04-27 |
Bristol-Myers Squibb Company |
Hepatitis C virus inhibitors
|
|
US8034966B1
(en)
*
|
2008-02-20 |
2011-10-11 |
Cell Viable Corporation |
Phenoxyisobutyric acid compounds and methods for synthesis
|
|
WO2009136290A1
(en)
|
2008-05-05 |
2009-11-12 |
Aegera Therapeutics, Inc. |
Functionalized pyrrolidines and use thereof as iap inhibitors
|
|
WO2009143361A1
(en)
|
2008-05-22 |
2009-11-26 |
Smithkline Beecham Corporation |
Amido anti-viral compounds
|
|
WO2009155709A1
(en)
|
2008-06-27 |
2009-12-30 |
Aegera Therapeutics Inc. |
Bridged secondary amines and use thereof as iap bir domain binding compounds
|
|
US20100068197A1
(en)
|
2008-07-11 |
2010-03-18 |
Myriad Pharmaceuticals, Inc. |
Pharmaceutical compounds as inhibitors of cell proliferation and the use thereof
|
|
US7906655B2
(en)
|
2008-08-07 |
2011-03-15 |
Bristol-Myers Squibb Company |
Hepatitis C virus inhibitors
|
|
WO2010015090A1
(en)
|
2008-08-07 |
2010-02-11 |
Aegera Therapeutics Inc. |
Functionalized pyrrolidines and use thereof as iap inhibitors
|
|
US8383094B2
(en)
|
2008-10-01 |
2013-02-26 |
Bristol-Myers Squibb Company |
Hepatitis C virus inhibitors
|
|
US8946289B2
(en)
|
2008-11-19 |
2015-02-03 |
Duke University |
Manassatin compounds and methods of making and using the same
|
|
JP2010126571A
(ja)
|
2008-11-26 |
2010-06-10 |
Toyo Ink Mfg Co Ltd |
有機エレクトロルミネッセンス素子材料および有機エレクトロルミネッセンス素子
|
|
US8729077B2
(en)
|
2008-11-28 |
2014-05-20 |
Glaxosmithkline Llc |
Anti-viral compounds, compositions, and methods of use
|
|
WO2010065668A1
(en)
|
2008-12-03 |
2010-06-10 |
Presidio Pharmaceuticals, Inc. |
Inhibitors of hcv ns5a
|
|
SI2373172T1
(sl)
|
2008-12-03 |
2013-12-31 |
Presidio Pharmaceuticals, Inc. |
Inhibitorji HCV NS5A
|
|
CA2740193A1
(en)
|
2008-12-23 |
2010-07-01 |
Abbott Laboratories |
Anti-viral compounds
|
|
EP2367823A1
(en)
*
|
2008-12-23 |
2011-09-28 |
Abbott Laboratories |
Anti-viral compounds
|
|
US8314135B2
(en)
*
|
2009-02-09 |
2012-11-20 |
Enanta Pharmaceuticals, Inc. |
Linked dibenzimidazole antivirals
|
|
EP2393359A4
(en)
|
2009-02-09 |
2012-10-03 |
Enanta Pharm Inc |
COMPOUND DIBENZIMIDAZOLE DERIVATIVES
|
|
US8394968B2
(en)
*
|
2009-02-17 |
2013-03-12 |
Bristol-Myers Squibb Company |
Hepatitis C virus inhibitors
|
|
US8420686B2
(en)
*
|
2009-02-17 |
2013-04-16 |
Enanta Pharmaceuticals, Inc. |
Linked diimidazole antivirals
|
|
US8188132B2
(en)
*
|
2009-02-17 |
2012-05-29 |
Enanta Pharmaceuticals, Inc. |
Linked dibenzimidazole derivatives
|
|
WO2010096462A1
(en)
|
2009-02-17 |
2010-08-26 |
Enanta Pharmaceuticals, Inc |
Linked diimidazole derivatives
|
|
US8242156B2
(en)
*
|
2009-02-17 |
2012-08-14 |
Enanta Pharmaceuticals, Inc. |
Linked dibenzimidazole derivatives
|
|
TWI438200B
(zh)
|
2009-02-17 |
2014-05-21 |
必治妥美雅史谷比公司 |
C型肝炎病毒抑制劑
|
|
US8637561B2
(en)
*
|
2009-02-17 |
2014-01-28 |
Enanta Pharmaceuticals, Inc. |
Linked diimidazole derivatives
|
|
WO2010094977A1
(en)
*
|
2009-02-23 |
2010-08-26 |
Arrow Therapeutics Limited |
Novel biphenyl compounds useful for the treatment of hepatitis c
|
|
WO2010096777A1
(en)
|
2009-02-23 |
2010-08-26 |
Presidio Pharmaceuticals, Inc. |
Inhibitors of hcv ns5a
|
|
US8426458B2
(en)
*
|
2009-02-27 |
2013-04-23 |
Enanta Pharmaceuticals, Inc. |
Hepatitis C Virus inhibitors
|
|
KR101411889B1
(ko)
|
2009-02-27 |
2014-06-27 |
이난타 파마슈티칼스, 인코포레이티드 |
C형 간염 바이러스 억제제
|
|
US8101643B2
(en)
*
|
2009-02-27 |
2012-01-24 |
Enanta Pharmaceuticals, Inc. |
Benzimidazole derivatives
|
|
US8507522B2
(en)
*
|
2009-03-06 |
2013-08-13 |
Enanta Pharmaceuticals, Inc. |
Hepatitis C virus inhibitors
|
|
SG174929A1
(en)
|
2009-03-27 |
2011-11-28 |
Merck Sharp & Dohme |
Inhibitors of hepatitis c virus replication
|
|
WO2010111673A1
(en)
|
2009-03-27 |
2010-09-30 |
Presidio Pharmaceuticals, Inc. |
Substituted bicyclic hcv inhibitors
|
|
SG174883A1
(en)
|
2009-03-27 |
2011-11-28 |
Presidio Pharmaceuticals Inc |
Fused ring inhibitors of hepatitis c
|
|
US20110237636A1
(en)
*
|
2009-03-30 |
2011-09-29 |
Bristol-Myers Squibb Company |
Hepatitis C Virus Inhibitors
|
|
US8796466B2
(en)
*
|
2009-03-30 |
2014-08-05 |
Bristol-Myers Squibb Company |
Hepatitis C virus inhibitors
|
|
TWI476190B
(zh)
*
|
2009-03-30 |
2015-03-11 |
必治妥美雅史谷比公司 |
C型肝炎病毒抑制劑
|
|
WO2010115767A1
(en)
|
2009-04-08 |
2010-10-14 |
Basf Se |
Pyrrolopyrrole derivatives, their manufacture and use as semiconductors
|
|
TW201038559A
(en)
*
|
2009-04-09 |
2010-11-01 |
Bristol Myers Squibb Co |
Hepatitis C virus inhibitors
|
|
US8143414B2
(en)
|
2009-04-13 |
2012-03-27 |
Bristol-Myers Squibb Company |
Hepatitis C virus inhibitors
|
|
CN102459165B
(zh)
|
2009-04-15 |
2015-09-02 |
Abbvie公司 |
抗病毒化合物
|
|
RU2528231C2
(ru)
|
2009-04-24 |
2014-09-10 |
Тиботек Фармасьютикалз |
Диариловые эфиры
|
|
WO2010132538A1
(en)
|
2009-05-12 |
2010-11-18 |
Schering Corporation |
Fused tricyclic aryl compounds useful for the treatment of viral diseases
|
|
PT3309157T
(pt)
|
2009-05-13 |
2019-12-02 |
Gilead Pharmasset Llc |
Compostos antivirais
|
|
US8211928B2
(en)
|
2009-05-29 |
2012-07-03 |
Bristol-Myers Squibb Company |
Hepatitis C virus inhibitors
|
|
US8138215B2
(en)
|
2009-05-29 |
2012-03-20 |
Bristol-Myers Squibb Company |
Hepatitis C virus inhibitors
|
|
US8772505B2
(en)
|
2009-05-29 |
2014-07-08 |
Merck Sharp & Dohme Corp. |
Antiviral compounds composed of three aligned aryl moieties to treat diseases such as hepatitis C
|
|
CA2763140A1
(en)
|
2009-05-29 |
2010-12-02 |
Schering Corporation |
Antiviral compounds composed of three linked aryl moieties to treat diseases such as hepatitis c
|
|
US8937150B2
(en)
|
2009-06-11 |
2015-01-20 |
Abbvie Inc. |
Anti-viral compounds
|
|
UA118080C2
(uk)
|
2009-06-11 |
2018-11-26 |
Еббві Айрленд Анлімітед Компані |
Противірусні сполуки
|
|
US9394279B2
(en)
*
|
2009-06-11 |
2016-07-19 |
Abbvie Inc. |
Anti-viral compounds
|
|
WO2010148006A1
(en)
|
2009-06-16 |
2010-12-23 |
Enanta Pharmaceuticals, Inc. |
Hepatitis c virus inhibitors
|
|
US8221737B2
(en)
|
2009-06-16 |
2012-07-17 |
Enanta Pharmaceuticals, Inc. |
Hepatitis C virus inhibitors
|
|
US8609648B2
(en)
*
|
2009-07-02 |
2013-12-17 |
Enanta Pharmaceuticals, Inc. |
Hepatitis C virus inhibitors
|
|
WO2011004276A1
(en)
|
2009-07-06 |
2011-01-13 |
Pfizer Limited |
Hepatitis c virus inhibitors
|
|
IN2012DN00999A
(https=)
|
2009-07-16 |
2015-04-10 |
Vertex Pharma |
|
|
CN102471324B
(zh)
|
2009-08-07 |
2014-12-17 |
泰博特克药品公司 |
作为丙型肝炎病毒抑制剂的双苯并咪唑衍生物
|
|
CN102482260A
(zh)
|
2009-09-03 |
2012-05-30 |
泰博特克药品公司 |
双-苯并咪唑衍生物
|
|
EA201290089A1
(ru)
|
2009-09-04 |
2012-09-28 |
ГЛАКСОСМИТКЛАЙН ЭлЭлСи |
Химические соединения
|
|
WO2011031904A1
(en)
|
2009-09-11 |
2011-03-17 |
Enanta Pharmaceuticals, Inc |
Hepatitis c virus inhibitors
|
|
EP2475254A4
(en)
|
2009-09-11 |
2013-05-22 |
Enanta Pharm Inc |
HEPATITIS C-VIRUS HEMMER
|
|
US8815928B2
(en)
*
|
2009-09-11 |
2014-08-26 |
Enanta Pharmaceuticals, Inc. |
Hepatitis C virus inhibitors
|
|
US8822700B2
(en)
*
|
2009-09-11 |
2014-09-02 |
Enanta Pharmaceuticals, Inc. |
Hepatitis C virus inhibitors
|
|
US8759332B2
(en)
*
|
2009-09-11 |
2014-06-24 |
Enanta Pharmaceuticals, Inc. |
Hepatitis C virus inhibitors
|
|
US8703938B2
(en)
*
|
2009-09-11 |
2014-04-22 |
Enanta Pharmaceuticals, Inc. |
Hepatitis C virus inhibitors
|
|
US8927709B2
(en)
*
|
2009-09-11 |
2015-01-06 |
Enanta Pharmaceuticals, Inc. |
Hepatitis C virus inhibitors
|
|
WO2011050146A1
(en)
|
2009-10-23 |
2011-04-28 |
Glaxosmithkline Llc |
Chemical compounds
|
|
UA108211C2
(uk)
|
2009-11-04 |
2015-04-10 |
Янссен Рід Айрленд |
Бензімідазолімідазольні похідні
|
|
US20110269956A1
(en)
|
2009-11-11 |
2011-11-03 |
Bristol-Myers Squibb Company |
Hepatitis C Virus Inhibitors
|
|
US20110274648A1
(en)
|
2009-11-11 |
2011-11-10 |
Bristol-Myers Squibb Company |
Hepatitis C Virus Inhibitors
|
|
US20110281910A1
(en)
*
|
2009-11-12 |
2011-11-17 |
Bristol-Myers Squibb Company |
Hepatitis C Virus Inhibitors
|
|
JP2013512246A
(ja)
|
2009-11-25 |
2013-04-11 |
メルク・シャープ・アンド・ドーム・コーポレーション |
ウイルス疾患治療に有用な縮合型三環式化合物およびその誘導体
|
|
EP2507232B1
(en)
|
2009-12-04 |
2019-03-20 |
National Health Research Institutes |
Proline derivatives
|
|
US8653070B2
(en)
*
|
2009-12-14 |
2014-02-18 |
Enanta Pharmaceuticals, Inc. |
Hepatitis C virus inhibitors
|
|
US8377980B2
(en)
*
|
2009-12-16 |
2013-02-19 |
Bristol-Myers Squibb Company |
Hepatitis C virus inhibitors
|
|
CN104530079B
(zh)
*
|
2009-12-18 |
2017-10-20 |
北京凯因科技股份有限公司 |
C型肝炎病毒复制的新型抑制剂
|
|
KR20120118008A
(ko)
*
|
2009-12-18 |
2012-10-25 |
아이데닉스 파마슈티칼스, 인코포레이티드 |
5,5-융합 아릴렌 또는 헤테로아릴렌 간염 c 바이러스 억제제
|
|
US20130156731A1
(en)
|
2009-12-22 |
2013-06-20 |
Kevin X. Chen |
Fused tricyclic compounds and methods of use thereof for the treatment of viral diseas
|
|
WO2011079327A1
(en)
|
2009-12-24 |
2011-06-30 |
Vertex Pharmaceuticals Incorporated |
Analogues for the treatment or prevention of flavivirus infections
|
|
US8362020B2
(en)
|
2009-12-30 |
2013-01-29 |
Bristol-Myers Squibb Company |
Hepatitis C virus inhibitors
|
|
WO2011091446A1
(en)
|
2010-01-22 |
2011-07-28 |
Glaxosmithkline Llc |
Chemical compounds
|
|
MA34013B1
(fr)
*
|
2010-01-25 |
2013-02-01 |
Enanta Pharm Inc |
Inhibiteurs du virus de l'hépatite c
|
|
WO2011091532A1
(en)
|
2010-01-28 |
2011-08-04 |
Boehringer Ingelheim International Gmbh |
Hepatitis c inhibitor compounds
|
|
US8178531B2
(en)
*
|
2010-02-23 |
2012-05-15 |
Enanta Pharmaceuticals, Inc. |
Antiviral agents
|
|
KR20120124495A
(ko)
*
|
2010-03-04 |
2012-11-13 |
이난타 파마슈티칼스, 인코포레이티드 |
Hcv 복제의 억제제로서의 조합 제약 작용제
|
|
EA201290882A1
(ru)
*
|
2010-03-09 |
2013-04-30 |
Мерк Шарп Энд Домэ Корп. |
Конденсированные трициклические силильные соединения и способы их применения для лечения вирусных заболеваний
|
|
TW201141857A
(en)
|
2010-03-24 |
2011-12-01 |
Vertex Pharma |
Analogues for the treatment or prevention of flavivirus infections
|
|
CN103038237A
(zh)
|
2010-03-24 |
2013-04-10 |
沃泰克斯药物股份有限公司 |
用于黄病毒感染治疗或预防的类似物
|
|
CA2794145A1
(en)
|
2010-03-24 |
2011-09-29 |
Vertex Pharmaceuticals Incorporated |
Analogues for the treatment or prevention of flavivirus infections
|
|
WO2011119858A1
(en)
|
2010-03-24 |
2011-09-29 |
Vertex Pharmaceuticals Incorporated |
Analogues for the treatment or prevention of flavivirus infections
|
|
EP2555622A4
(en)
|
2010-04-09 |
2013-09-18 |
Enanta Pharm Inc |
HEPATITIS C-VIRUS HEMMER
|
|
US20110312996A1
(en)
|
2010-05-17 |
2011-12-22 |
Intermune, Inc. |
Novel inhibitors of hepatitis c virus replication
|
|
WO2011150243A1
(en)
|
2010-05-28 |
2011-12-01 |
Presidio Pharmaceuticals, Inc. |
Inhibitors of hcv ns5a
|
|
EP2575819A4
(en)
|
2010-06-04 |
2013-11-27 |
Enanta Pharm Inc |
INHIBITORS OF HEPATITIS C VIRUS
|
|
EP2580209A4
(en)
|
2010-06-09 |
2013-11-06 |
Presidio Pharmaceuticals Inc |
INHIBITORS OF HCV NS5A PROTEIN
|
|
NZ605440A
(en)
|
2010-06-10 |
2014-05-30 |
Abbvie Bahamas Ltd |
Solid compositions comprising an hcv inhibitor
|
|
MX2013006828A
(es)
*
|
2010-12-16 |
2014-10-14 |
Abbvie Inc |
Compuestos antivirales.
|
|
MX2013006951A
(es)
|
2010-12-16 |
2013-10-03 |
Abbvie Inc |
Compuestos antivirales.
|